EvolveImmune Therapeutics

📍 Branford, United States🗓 Founded 2020👥 35 employees💰 Last funded Jan 2020
Biotechnology Research🌐 evolveimmune.com
Website LinkedIn
At EvolveImmune, we harness our “Immunology First” approach to create first-in-category cancer medicines to transform the lives of patients by delivering superior, long-term outcomes compared to current anti-cancer therapies. We are pioneers who rapidly translate discoveries into innovations and innovations into differentiated therapeutic solutions, to address the most significant unmet medical needs in oncology. We are based in Branford, CT and Farmington, CT.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in EvolveImmune Therapeutics?
EvolveImmune Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did EvolveImmune Therapeutics last raise funding?
The most recent investment in EvolveImmune Therapeutics recorded on gritt.io was in January 2020.
When was EvolveImmune Therapeutics founded?
EvolveImmune Therapeutics was founded in 2020.
What industry is EvolveImmune Therapeutics in?
EvolveImmune Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is EvolveImmune Therapeutics based?
EvolveImmune Therapeutics is headquartered in Branford, United States.